135 related articles for article (PubMed ID: 2208160)
1. Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening.
Zhou DJ; Pompon D; Chen SA
Cancer Res; 1990 Nov; 50(21):6949-54. PubMed ID: 2208160
[TBL] [Abstract][Full Text] [Related]
2. Expression of human placental aromatase in Saccharomyces cerevisiae.
Pompon D; Liu RY; Besman MJ; Wang PL; Shively JE; Chen S
Mol Endocrinol; 1989 Sep; 3(9):1477-87. PubMed ID: 2691883
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
MacIndoe JH; Woods GR; Etre LA; Covey DF
Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
[TBL] [Abstract][Full Text] [Related]
4. Different catalytic properties and inhibitor responses of the goldfish brain and ovary aromatase isozymes.
Zhao J; Mak P; Tchoudakova A; Callard G; Chen S
Gen Comp Endocrinol; 2001 Aug; 123(2):180-91. PubMed ID: 11482939
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
6. A site-directed mutagenesis study of human placental aromatase.
Zhou DJ; Korzekwa KR; Poulos T; Chen SA
J Biol Chem; 1992 Jan; 267(2):762-8. PubMed ID: 1730667
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of goat ovarian aromatase cDNA: assessment of the activity using an intact cell system and placental expression.
Bobes RJ; Miranda C; Pérez-Martinez M; Luu-The V; Romano MC
Theriogenology; 2004 Aug; 62(3-4):532-43. PubMed ID: 15226009
[TBL] [Abstract][Full Text] [Related]
8. Regulation of aromatase expression in the ovary and placenta: a comparison between two species.
Hinshelwood MM; Dodson Michael M; Sun T; Simpson ER
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):399-405. PubMed ID: 9365217
[TBL] [Abstract][Full Text] [Related]
9. A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene.
Yue W; Zhou D; Chen S; Brodie A
Cancer Res; 1994 Oct; 54(19):5092-5. PubMed ID: 7923123
[TBL] [Abstract][Full Text] [Related]
10. Identification of the aromatase in the breast carcinoma cell lines T47D and MCF-7.
Sadekova SI; Tan L; Chow TY
Anticancer Res; 1994; 14(2A):507-11. PubMed ID: 8017854
[TBL] [Abstract][Full Text] [Related]
11. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
[TBL] [Abstract][Full Text] [Related]
12. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
Kao YC; Okubo T; Sun XZ; Chen S
Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
[TBL] [Abstract][Full Text] [Related]
13. Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells.
Martínez-Campa C; González A; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
Breast Cancer Res Treat; 2005 Dec; 94(3):249-54. PubMed ID: 16244789
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibition by an enzyme-activated irreversible inhibitor in human carcinoma cell cultures.
Brueggemeier RW; Katlic NE
Cancer Res; 1990 Jun; 50(12):3652-6. PubMed ID: 2340513
[TBL] [Abstract][Full Text] [Related]
15. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors.
Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M
Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
Swinney DC; Watson DM; So OY
Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
[TBL] [Abstract][Full Text] [Related]
17. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
18. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
19. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885
[TBL] [Abstract][Full Text] [Related]
20. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
